|
WO2017117333A1
|
|
Microtissue formation using stem cell-derived human hepatocytes
|
|
CA2997763A1
|
|
Macs-based purification of stem cell-derived retinal pigment epithelium
|
|
AU2015255253A1
|
|
Methods for the production of ips cells
|
|
WO2016061071A1
|
|
Generation of keratinocytes from pluripotent stem cells and maintenance of keratinocyte cultures
|
|
US2017107486A1
|
|
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
|
WO2015143342A1
|
|
Production of midbrain dopaminergic neurons and methods for the use thereof
|
|
US2016219843A1
|
|
Mouse model for engraftment potential
|
|
WO2014130770A1
|
|
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
|
EP2737056A1
|
|
Metabolic maturation in stem cell-derived tissue cells
|
|
WO2013009825A1
|
|
Methods for cell reprogramming and genome engineering
|
|
EP2694644A2
|
|
Priming of pluripotent stem cells for neural differentiation
|
|
WO2012109208A2
|
|
Hematopoietic precursor cell production by programming
|
|
CA2806858A1
|
|
Reprogramming immortalized b cells
|
|
CA2802525A1
|
|
Cardiomyocyte medium with dialyzed serum
|
|
WO2011159797A2
|
|
A compendium of ready-built stem cell models for interrogation of biological response
|
|
WO2011159684A2
|
|
Generation of induced pluripotent stem cells from small volumes of peripheral blood
|
|
CA2796251A1
|
|
Hepatocyte production by forward programming
|
|
EP2496689A2
|
|
Episomal reprogramming with chemicals
|
|
WO2011056416A2
|
|
Cardiomyocyte production
|
|
WO2011025852A1
|
|
Identifying genetic variation in affected tissues
|
